Physiological, pharmacological and clinical features of the multidrug resistance protein 2

Biomedicine and Pharmacotherapy

Volumn 59, Issue 3, 2005, Pages 104-114

  Fardel, Olivier ^a   Jigorel, Emilie ^a   Le Vee, Marc ^a   Payen, Lea ^a  

^a INSERM   (France)

Author keywords

Drug resistance; MRP2, Pharmacokinetic

Indexed keywords

6 (4 HYDROXYPHENYL) 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; AMPICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; AZITHROMYCIN; BILIRUBIN; CAMPTOTHECIN; CEFTRIAXONE; CISPLATIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOSPORIN A; FLAVONOID; FLUORESCENT DYE; GLIBENCLAMIDE; GREPAFLOXACIN; INDINAVIR; INDOMETACIN; IRINOTECAN; METHOTREXATE; MIFEPRISTONE; MULTIDRUG RESISTANCE PROTEIN 2; PARACETAMOL; PRAVASTATIN; PROBENECID; PROTEINASE INHIBITOR; RIFAMPICIN; RITONAVIR; SAQUINAVIR; TEMOCAPRILAT; UNINDEXED DRUG; VERLUKAST; VINBLASTINE; XENOBIOTIC AGENT;

AMINO TERMINAL SEQUENCE; CLINICAL FEATURE; DRUG BINDING; DRUG DISPOSITION; DRUG TRANSPORT; HUMAN; IMMUNODETECTION; NONHUMAN; PHARMACOLOGICAL PARAMETERS; PHENOTYPE; PHYSIOLOGY; PREGNANCY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; TRANSCRIPTION INITIATION; TUMOR CELL;

EID: 15744368796     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2005.01.005     Document Type: Article

References (165)

1. C.C. Paulusma, P.J. Bosma, and G.J. Zaman Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene Science 271 1996 1126 1128
2. M. Buchler, J. Konig, and M. Brom cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats J. Biol. Chem. 271 1996 15091 15098
3. K. Ito, H. Suzuki, T. Hirohashi, K. Kume, T. Shimizu, and Y. Sugiyama Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR Am. J. Physiol. 272 1997 G16 G22
4. G.D. Kruh, and M.G. Belinsky The MRP family of drug efflux pumps Oncogene 22 2003 7537 7552
5. G.E. Tusnady, E. Bakos, A. Varadi, and B. Sarkadi Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters FEBS Lett. 402 1997 1 3
6. L. Homolya, A. Varadi, and B. Sarkadi Multidrug resistance-associated proteins: export pumps for conjugates with glutathione, glucuronate or sulfate Biofactors 17 2003 103 114
7. H. Kusuhara, and Y. Sugiyama Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney J. Control. Release 78 2002 43 54
8. L.M. Chan, S. Lowes, and B.H. Hirst The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability Eur. J. Pharm. Sci. 21 2004 25 51
9. P. Chandra, and K.L. Brouwer The complexities of hepatic drug transport: current knowledge and emerging concepts Pharm. Res. 21 2004 719 735
10. P. Borst, M. Kool, and R. Evers Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? Semin. Cancer Biol. 8 1997 205 213
11. T. Iyanagi, Y. Emi, and S. Ikushiro Biochemical and molecular aspects of genetic disorders of bilirubin metabolism Biochim. Biophys. Acta 1407 1998 173 184
12. S. Toh, M. Wada, and T. Uchiumi Genomic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome Am. J. Hum. Genet. 64 1999 739 746
13. P. Borst, R. Evers, M. Kool, and J. Wijnholds A family of drug transporters: the multidrug resistance-associated proteins J. Natl. Cancer Inst. 92 2000 1295 1302
14. E.M. Leslie, R.G. Deeley, and S.P. Cole Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters Toxicology 167 2001 3 23
15. S. Ryu, T. Kawabe, S. Nada, and A. Yamaguchi Identification of basic residues involved in drug export function of human multidrug resistance-associated protein 2 J. Biol. Chem. 275 2000 39617 39624
16. K. Ito, H. Suzuki, and Y. Sugiyama Charged amino acids in the transmembrane domains are involved in the determination of the substrate specificity of rat Mrp2 Mol. Pharmacol. 59 2001 1077 1085
17. K. Ito, C.J. Oleschuk, C. Westlake, M.Z. Vasa, R.G. Deeley, and S.P. Cole Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity J. Biol. Chem. 276 2001 38108 38114
18. N. Zelcer, M.T. Huisman, and G. Reid Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2) J. Biol. Chem. 278 2003 23538 23544
19. S.B. Fernandez, Z. Hollo, and A. Kern Role of the N-terminal transmembrane region of the multidrug resistance protein MRP2 in routing to the apical membrane in MDCKII cells J. Biol. Chem. 277 2002 31048 31055
20. O. Kocher, N. Comella, and A. Gilchrist PDZK1, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome 1q21, interacts with cMOAT (MRP2), the multidrug resistance-associated protein Lab. Invest. 79 1999 1161 1170
21. T. Hegedus, T. Sessler, and R. Scott C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins Biochem. Biophys. Res. Commun. 302 2003 454 461
22. A.T. Nies, J. Konig, Y. Cui, M. Brom, H. Spring, and D. Keppler Structural requirements for the apical sorting of human multidrug resistance protein 2 (ABCC2) Eur. J. Biochem. 269 2002 1866 1876
23. D. Keppler, J. Konig, and M. Buchler The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes Adv. Enzyme Regul. 37 1997 321 333
24. A.D. Mottino, T. Hoffman, L. Jennes, J. Cao, and M. Vore Expression of multidrug resistance-associated protein 2 in small intestine from pregnant and postpartum rats Am. J. Physiol. Gastrointest. Liver Physiol. 280 2001 G1261 G1273
25. D. Rost, J. Konig, G. Weiss, E. Klar, W. Stremmel, and D. Keppler Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia Gastroenterology 121 2001 1203 1208
26. N.J. Cherrington, D.P. Hartley, N. Li, D.R. Johnson, and C.D. Klaassen Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats J. Pharmacol. Exp. Ther. 300 2002 97 104
27. K. Oselin, P.M. Mrozikiewicz, R. Pahkla, and I. Roots Quantitative determination of the human MRP1 and MRP2 mRNA expression in FACS-sorted peripheral blood CD4+, CD8+, CD19+, and CD56+ cells Eur. J. Haematol. 71 2003 119 123
28. D.R. Johnson, G.L. Guo, and C.D. Klaassen Expression of rat multidrug resistance protein 2 (Mrp2) in male and female rats during normal and pregnenolone-16alpha-carbonitrile (PCN)-induced postnatal ontogeny Toxicology 178 2002 209 219
29. Y. Zhang, H. Han, W.F. Elmquist, and D.W. Miller Expression of various multidrug resistance-associated protein (MRP) homologues in brain microvessel endothelial cells Brain Res. 876 2000 148 153
30. A.T. Nies, G. Jedlitschky, and J. Konig Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain Neuroscience 129 2004 349 360
31. D.S. Miller, S.N. Nobmann, H. Gutmann, M. Toeroek, J. Drewe, and G. Fricker Xenobiotic transport across isolated brain microvessels studied by confocal microscopy Mol. Pharmacol. 58 2000 1357 1367
32. H. Potschka, M. Fedrowitz, and W. Loscher Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity J. Pharmacol. Exp. Ther. 306 2003 124 131
33. J. Bart, H. Hollema, and H.J. Groen The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours Eur. J. Cancer 40 2004 2064 2070
34. S. Choudhuri, N.J. Cherrington, N. Li, and C.D. Klaassen Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats Drug Metab. Dispos. 31 2003 1337 1345
35. G. Tomer, M. Ananthanarayanan, A. Weymann, N. Balasubramanian, and F.J. Suchy Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2 Pediatr. Res. 53 2003 288 294
36. J.E. Ros, T.A. Roskams, and M. Geuken ATP binding cassette transporter gene expression in rat liver progenitor cells Gut 52 2003 1060 1067
37. M.V. St-Pierre, M.A. Serrano, and R.I. Macias Expression of members of the multidrug resistance protein family in human term placenta Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 2000 R1495 R1503
38. J. Cao, B. Stieger, P.J. Meier, and M. Vore Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy Am. J. Physiol. Gastrointest. Liver Physiol. 283 2002 G757 G766
39. J. Konig, A.T. Nies, Y. Cui, I. Leier, and D. Keppler Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance Biochim. Biophys. Acta 1461 1999 377 394
40. D. Keppler, and J. Konig Hepatic secretion of conjugated drugs and endogenous substances Semin. Liver Dis. 20 2000 265 272
41. G. Jedlitschky, and D. Keppler Transport of leukotriene C4 and structurally related conjugates Vitam. Horm. 64 2002 153 184
42. H. Suzuki, and Y. Sugiyama Excretion of GSSG and glutathione conjugates mediated by MRP1 and cMOAT/MRP2 Semin. Liver Dis. 18 1998 359 376
43. N. Ballatori, and J.F. Rebbeor Roles of MRP2 and oatp1 in hepatocellular export of reduced glutathione Semin. Liver Dis. 18 1998 377 387
44. S.V. Kala, M.W. Neely, and G. Kala The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic J. Biol. Chem. 275 2000 33404 33408
45. T. Kamisako, I. Leier, and Y. Cui Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2 Hepatology 30 1999 485 490
46. G. Jedlitschky, I. Leier, U. Buchholz, J. Hummel-Eisenbeiss, B. Burchell, and D. Keppler ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2 Biochem. J. 327 Pt 1 1997 305 310
47. X.Y. Chu, S.E. Huskey, M.P. Braun, B. Sarkadi, D.C. Evans, and R. Evers Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3 J. Pharmacol. Exp. Ther. 309 2004 156 164
48. H. Xiong, K.C. Turner, E.S. Ward, P.L. Jansen, and K.L. Brouwer Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistance-associated protein 2-deficient TR(-) rats J. Pharmacol. Exp. Ther. 295 2000 512 518
49. H. Akita, H. Suzuki, and K. Ito Characterization of bile acid transport mediated by multidrug resistance associated protein 2 and bile salt export pump Biochim. Biophys. Acta 1511 2001 7 16
50. M. Trauner, and J.L. Boyer Bile salt transporters: molecular characterization, function, and regulation Physiol. Rev. 83 2003 633 671
51. H. Tanaka, N. Sano, and H. Takikawa Biliary excretion of phenolphthalein sulfate in rats Pharmacology 68 2003 177 182
52. J.H. Hooijberg, H.J. Broxterman, and M. Kool Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2 Cancer Res. 59 1999 2532 2535
53. G. Toffoli, E. Cecchin, G. Corona, and M. Boiocchi Pharmacogenetics of irinotecan Curr. Med. Chem. Anti-Canc. Agents 3 2003 225 237
54. L. Accatino, M. Pizarro, N. Solis, M. Arrese, and C.S. Koenig Bile secretory function after warm hepatic ischemia-reperfusion injury in the rat Liver Transpl. 9 2003 1199 1210
55. M. Sasaki, H. Suzuki, K. Ito, T. Abe, and Y. Sugiyama Transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II cell monolayer expressing both human organic anion-transporting polypeptide (OATP2/SLC21A6) and multidrug resistance-associated protein 2 (MRP2/ABCC2) J. Biol. Chem. 277 2002 6497 6503
56. M. Sasaki, H. Suzuki, J. Aoki, K. Ito, P.J. Meier, and Y. Sugiyama Prediction of in vivo biliary clearance from the in vitro transcellular transport of organic anions across a double-transfected Madin-Darby canine kidney II monolayer expressing both rat organic anion transporting polypeptide 4 and multidrug resistance associated protein 2 Mol. Pharmacol. 66 2004 450 459
57. I. Leier, J. Hummel-Eisenbeiss, Y. Cui, and D. Keppler ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2 Kidney Int. 57 2000 1636 1642
58. T. Cantz, A.T. Nies, M. Brom, A.F. Hofmann, and D. Keppler MRP2, a human conjugate export pump, is present and transports fluo 3 into apical vacuoles of Hep G2 cells Am. J. Physiol. Gastrointest. Liver Physiol. 278 2000 G522 G531
59. M.J. Zamek-Gliszczynski, H. Xiong, N.J. Patel, R.Z. Turncliff, G.M. Pollack, and K.L. Brouwer Pharmacokinetics of 5 (and 6)-carboxy-2',7'- dichlorofluorescein and its diacetate promoiety in the liver J. Pharmacol. Exp. Ther. 304 2003 801 809
60. K. Hashimoto, T. Uchiumi, and T. Konno Trafficking and functional defects by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson syndrome Hepatology 36 2002 1236 1245
61. L. Payen, A. Courtois, J.P. Campion, A. Guillouzo, and O. Fardel Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes Biochem. Pharmacol. 60 2000 1967 1975
62. C.C. Paulusma, M.J. Kothe, and C.T. Bakker Zonal down-regulation and redistribution of the multidrug resistance protein 2 during bile duct ligation in rat liver Hepatology 31 2000 684 693
63. C. Chen, D. Scott, and E. Hanson Impact of Mrp2 on the biliary excretion and intestinal absorption of furosemide, probenecid, and methotrexate using Eisai hyperbilirubinemic rats Pharm. Res. 20 2003 31 37
64. R. Evers, M. de Haas, and R. Sparidans Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export Br. J. Cancer 83 2000 375 383
65. K.A. Hoffmaster, M.J. Zamek-Gliszczynski, G.M. Pollack, and K.L. Brouwer Hepatobiliary disposition of the metabolically stable opioid peptide [d-penicillamine2,5]enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems J. Pharmacol. Exp. Ther. 311 2004 1203 1210
66. J. Hong, J.D. Lambert, S.H. Lee, P.J. Sinko, and C.S. Yang Involvement of multidrug resistance-associated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites Biochem. Biophys. Res. Commun. 310 2003 222 227
67. M.T. Huisman, J.W. Smit, and K.M. Crommentuyn Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs AIDS 16 2002 2295 2301
68. M. Sugie, E. Asakura, and Y.L. Zhao Possible involvement of the drug transporters P glycoprotein and multidrug resistance-associated protein Mrp2 in disposition of azithromycin Antimicrob. Agents Chemother. 48 2004 809 814
69. T. Takada, H.M. Weiss, O. Kretz, G. Gross, and Y. Sugiyama Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154 Drug Metab. Dispos. 32 2004 1272 1278
70. N.J. Patel, M.J. Zamek-Gliszczynski, and P. Zhang Phenobarbital alters hepatic Mrp2 function by direct and indirect interactions Mol. Pharmacol. 64 2003 154 159
71. W. Jager, E. Gehring, B. Hagenauer, S. Aust, A. Senderowicz, and T. Thalhammer Biliary excretion of flavopiridol and its glucuronides in the isolated perfused rat liver: role of multidrug resistance protein 2 (Mrp2) Life Sci. 73 2003 2841 2854
72. C.G. Dietrich, D.R. de Waart, R. Ottenhoff, I.G. Schoots, and R.P. Elferink Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats Mol. Pharmacol. 59 2001 974 980
73. V. Berger, A.F. Gabriel, T. Sergent, A. Trouet, Y. Larondelle, and Y.J. Schneider Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2) Toxicol. Lett. 140 2003 465 476 -141
74. E. Bakos, R. Evers, E. Sinko, A. Varadi, P. Borst, and B. Sarkadi Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions Mol. Pharmacol. 57 2000 760 768
75. R.A. Van Aubel, J.B. Koenderink, J.G. Peters, C.H. Van Os, and F.G. Russel Mechanisms and interaction of vinblastine and reduced glutathione transport in membrane vesicles by the rabbit multidrug resistance protein Mrp2 expressed in insect cells Mol. Pharmacol. 56 1999 714 719
76. C.G. Dietrich, R. Ottenhoff, D.R. de Waart, and R.P. Oude Elferink Role of MRP2 and GSH in intrahepatic cycling of toxins Toxicology 167 2001 73 81
77. X. Li, and S.A. Weinman Mrp2 modulates the activity of chloride channels in isolated hepatocytes Hepatology 36 2002 65 71
78. E. Asakura, H. Nakayama, and M. Sugie Azithromycin reverses anticancer drug resistance and modifies hepatobiliary excretion of doxorubicin in rats Eur. J. Pharmacol. 484 2004 333 339
79. J.F. Rebbeor, G.C. Connolly, and N. Ballatori Inhibition of Mrp2- and Ycf1p-mediated transport by reducing agents: evidence for GSH transport on rat Mrp2 Biochim. Biophys. Acta 1559 2002 171 178
80. E.J. Wang, and W.W. Johnson The farnesyl protein transferase inhibitor lonafarnib (SCH66336) is an inhibitor of multidrug resistance proteins 1 and 2 Chemotherapy 49 2003 303 308
81. K. Arimori, N. Kuroki, and M. Hidaka Effect of P-glycoprotein modulator, cyclosporin A, on the gastrointestinal excretion of irinotecan and its metabolite SN-38 in rats Pharm. Res. 20 2003 910 917
82. S.R. Vavricka, J. Van Montfoort, H.R. Ha, P.J. Meier, and K. Fattinger Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver Hepatology 36 2002 164 172
83. B. Stieger, K. Fattinger, J. Madon, G.A. Kullak-Ublick, and P.J. Meier Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver Gastroenterology 118 2000 422 430
84. H.R. Kast, B. Goodwin, and P.T. Tarr Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor J. Biol. Chem. 277 2002 2908 2915
85. P. Fickert, G. Zollner, and A. Fuchsbichler Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver Gastroenterology 121 2001 170 183
86. G. Zollner, P. Fickert, and A. Fuchsbichler Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine J. Hepatol. 39 2003 480 488
87. G. Paumgartner, and U. Beuers Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited Hepatology 36 2002 525 531
88. U. Beuers, M. Bilzer, and A. Chittattu Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver Hepatology 33 2001 1206 1216
89. B. Goodwin, K.C. Gauthier, and M. Umetani Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor Proc. Natl. Acad. Sci. USA 100 2003 223 228
90. M. Demeule, J. Jodoin, E. Beaulieu, M. Brossard, and R. Beliveau Dexamethasone modulation of multidrug transporters in normal tissues FEBS Lett. 442 1999 208 214
91. D.R. Johnson, and C.D. Klaassen Regulation of rat multidrug resistance protein 2 by classes of prototypical microsomal enzyme inducers that activate distinct transcription pathways Toxicol. Sci. 67 2002 182 189
92. R. Kubitz, U. Warskulat, M. Schmitt, and D. Haussinger Dexamethasone- and osmolarity-dependent expression of the multidrug-resistance protein 2 in cultured rat hepatocytes Biochem. J. 340 Pt 3 1999 585 591
93. R.Z. Turncliff, P.J. Meier, and K.L. Brouwer Effect of dexamethasone treatment on the expression and function of transport proteins in sandwich-cultured rat hepatocytes Drug Metab. Dispos. 32 2004 834 839
94. A. Courtois, L. Payen, A. Guillouzo, and O. Fardel Up-regulation of multidrug resistance-associated protein 2 (MRP2) expression in rat hepatocytes by dexamethasone FEBS Lett. 459 1999 381 385
95. S. Teng, and M. Piquette-Miller The involvement of Pxr in hepatic gene regulation during inflammation in mice J. Pharmacol. Exp. Ther. 312 2005 841 848
96. S.A. Kliewer, J.T. Moore, and L. Wade An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway Cell 92 1998 73 82
97. R. Masereeuw, S.A. Terlouw, R.A. Van Aubel, F.G. Russel, and D.S. Miller Endothelin B receptor-mediated regulation of ATP-driven drug secretion in renal proximal tubule Mol. Pharmacol. 57 2000 59 67
98. S. Notenboom, D.S. Miller, P. Smits, F.G. Russel, and R. Masereeuw Role of NO in endothelin-regulated drug transport in the renal proximal tubule Am. J. Physiol. Renal Physiol. 282 2002 F458 F464
99. S. Notenboom, D.S. Miller, P. Smits, F.G. Russel, and R. Masereeuw Involvement of guanylyl cyclase and cGMP in the regulation of Mrp2-mediated transport in the proximal tubule Am. J. Physiol. Renal Physiol. 287 2004 F33 F38
100. S.A. Terlouw, R. Masereeuw, F.G. Russel, and D.S. Miller Nephrotoxicants induce endothelin release and signaling in renal proximal tubules: effect on drug efflux Mol. Pharmacol. 59 2001 1433 1440
101. L.A. Denson, A. Bohan, M.A. Held, and J.L. Boyer Organ-specific alterations in RAR alpha:RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis Gastroenterology 123 2002 599 607
102. K. Hisaeda, A. Inokuchi, and T. Nakamura Interleukin-1beta represses MRP2 gene expression through inactivation of interferon regulatory factor 3 in HepG2 cells Hepatology 39 2004 1574 1582
103. L.A. Denson, K.L. Auld, D.S. Schiek, M.H. McClure, D.J. Mangelsdorf, and S.J. Karpen Interleukin-1beta suppresses retinoid transactivation of two hepatic transporter genes involved in bile formation J. Biol. Chem. 275 2000 8835 8843
104. C.G. Dietrich, A. Geier, and N. Salein Consequences of bile duct obstruction on intestinal expression and function of multidrug resistance-associated protein 2 Gastroenterology 126 2004 1044 1053
105. J. Nakamura, T. Nishida, and K. Hayashi Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression Biochem. Biophys. Res. Commun. 255 1999 143 149
106. A. Geier, C.G. Dietrich, and S. Voigt Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis Hepatology 38 2003 345 354
107. A. Bohan, W.S. Chen, L.A. Denson, M.A. Held, and J.L. Boyer Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis J. Biol. Chem. 278 2003 36688 36698
108. G. Hartmann, A.K. Cheung, and M. Piquette-Miller Inflammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia J. Pharmacol. Exp. Ther. 303 2002 273 281
109. P.K. Kim, J. Chen, K.M. Andrejko, and C.S. Deutschman Intraabdominal sepsis down-regulates transcription of sodium taurocholate cotransporter and multidrug resistance-associated protein in rats Shock 14 2000 176 181
110. E. Siewert, C.G. Dietrich, and F. Lammert Interleukin-6 regulates hepatic transporters during acute-phase response Biochem. Biophys. Res. Commun. 322 2004 232 238
111. L. Vernhet, M.P. Seite, N. Allain, A. Guillouzo, and O. Fardel Arsenic induces expression of the multidrug resistance-associated protein 2 (MRP2) gene in primary rat and human hepatocytes J. Pharmacol. Exp. Ther. 298 2001 234 239
112. H.M. Kauffmann, S. Pfannschmidt, and H. Zoller Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression Toxicology 171 2002 137 146
113. J. Liu, H. Chen, and D.S. Miller Overexpression of glutathione S-transferase II and multidrug resistance transport proteins is associated with acquired tolerance to inorganic arsenic Mol. Pharmacol. 60 2001 302 309
114. H.M. Kauffmann, D. Keppler, J. Kartenbeck, and D. Schrenk Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes Hepatology 26 1997 980 985
115. D. Schrenk, P.R. Baus, N. Ermel, C. Klein, B. Vorderstemann, and H.M. Kauffmann Up-regulation of transporters of the MRP family by drugs and toxins Toxicol. Lett. 120 2001 51 57
116. M. Demeule, M. Brossard, and R. Beliveau Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter Am. J. Physiol. 277 1999 F832 F840
117. D. Laouari, R. Yang, C. Veau, I. Blanke, and G. Friedlander Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure Am. J. Physiol. Renal Physiol. 280 2001 F636 F645
118. H.M. Kauffmann, and D. Schrenk Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene Biochem. Biophys. Res. Commun. 245 1998 325 331
119. B. Stockel, J. Konig, A.T. Nies, Y. Cui, M. Brom, and D. Keppler Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison with the multidrug resistance protein 3 (MRP3) gene Eur. J. Biochem. 267 2000 1347 1358
120. K.W. Bock, T. Eckle, M. Ouzzine, and S. Fournel-Gigleux Coordinate induction by antioxidants of UDP-glucuronosyltransferase UGT1A6 and the apical conjugate export pump MRP2 (multidrug resistance protein 2) in Caco-2 cells Biochem. Pharmacol. 59 2000 467 470
121. M.F. Fromm, H.M. Kauffmann, and P. Fritz The effect of rifampin treatment on intestinal expression of human MRP transporters Am. J. Pathol. 157 2000 1575 1580
122. L. Payen, L. Sparfel, A. Courtois, L. Vernhet, A. Guillouzo, and O. Fardel The drug efflux pump MRP2: regulation of expression in physiopathological situations and by endogenous and exogenous compounds Cell Biol. Toxicol. 18 2002 221 233
123. R. Ruhl, R. Sczech, N. Landes, P. Pfluger, D. Kluth, and F.J. Schweigert Carotenoids and their metabolites are naturally occurring activators of gene expression via the pregnane X receptor Eur. J. Nutr. 43 2004 1 8
124. Y. Shibayama, R. Ikeda, T. Motoya, and K. Yamada St. John's Wort (Hypericum perforatum) induces overexpression of multidrug resistance protein 2 (MRP2) in rats: a 30-day ingestion study Food Chem. Toxicol. 42 2004 995 1002
125. T.W. Synold, I. Dussault, and B.M. Forman The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux Nat. Med. 7 2001 584 590
126. V.A. Catania, E.J. Sanchez Pozzi, and M.G. Luquita Co-regulation of expression of phase II metabolizing enzymes and multidrug resistance-associated protein 2 Ann Hepatol 3 2004 11 17
127. M. Magnarin, M. Morelli, and A. Rosati Induction of proteins involved in multidrug resistance (P-glycoprotein, MRP1, MRP2, LRP) and of CYP 3A4 by rifampicin in LLC-PK1 cells Eur. J. Pharmacol. 483 2004 19 28
128. A. Courtois, L. Payen, L. Vernhet, F. Morel, A. Guillouzo, and O. Fardel Differential regulation of canalicular multispecific organic anion transporter (cMOAT) expression by the chemopreventive agent oltipraz in primary rat hepatocytes and in rat liver Carcinogenesis 20 1999 2327 2330
129. L. Payen, A. Courtois, M. Loewert, A. Guillouzo, and O. Fardel Reactive oxygen species-related induction of multidrug resistance-associated protein 2 expression in primary hepatocytes exposed to sulforaphane Biochem. Biophys. Res. Commun. 282 2001 257 263
130. Y.C. Lin-Lee, S. Tatebe, N. Savaraj, T. Ishikawa, and M. Tien Kuo Differential sensitivities of the MRP gene family and gamma-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status Biochem. Pharmacol. 61 2001 555 563
131. M. Demeule, M. Brossard, S. Turcotte, A. Regina, J. Jodoin, and R. Beliveau Diallyl disulfide, a chemopreventive agent in garlic, induces multidrug resistance-associated protein 2 expression Biochem. Biophys. Res. Commun. 324 2004 937 945
132. A. Courtois, L. Payen, and E. Le Ferrec Differential regulation of multidrug resistance-associated protein 2 (MRP2) and cytochromes P450 2B1/2 and 3A1/2 in phenobarbital-treated hepatocytes Biochem. Pharmacol. 63 2002 333 341
133. E. Assenat, S. Gerbal-Chaloin, and D. Larrey Interleukin 1beta inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance Hepatology 40 2004 951 960
134. C.I. Ghanem, P.C. Gomez, and M.C. Arana Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein Biochem. Pharmacol. 68 2004 791 798
135. A.M. Wielandt, V. Vollrath, M. Manzano, S. Miranda, L. Accatino, and J. Chianale Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5- trichlorophenoxyacetic acid in the mouse liver Biochem. J. 341 Pt 1 1999 105 111
136. H.M. Kauffmann, D. Keppler, T.W. Gant, and D. Schrenk Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen Arch. Toxicol. 72 1998 763 768
137. J. Shoda, T. Miura, and H. Utsunomiya Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver Hepatology 39 2004 167 178
138. C.C. Paulusma, M. Kool, and P.J. Bosma A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome Hepatology 25 1997 1539 1542
139. V. Keitel, J. Kartenbeck, A.T. Nies, H. Spring, M. Brom, and D. Keppler Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome Hepatology 32 2000 1317 1328
140. V. Keitel, A.T. Nies, M. Brom, J. Hummel-Eisenbeiss, H. Spring, and D. Keppler A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2) Am. J. Physiol. Gastrointest. Liver Physiol. 284 2003 G165 G174
141. R. Mor-Cohen, A. Zivelin, N. Rosenberg, M. Shani, S. Muallem, and U. Seligsohn Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome J. Biol. Chem. 276 2001 36923 36930
142. Y. Kawabata, H. Nakamura, and E. Kamada Mechanism of hepatobiliary transport of a novel thromboxane A2 receptor antagonist, [2-(4- chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335), and its xenobiotic taurine conjugate (Z-335-Tau) in rats J. Pharm. Sci. 92 2003 67 76
143. N. Kobayashi, T. Tani, A. Hisaka, K. Hara, and T. Yasumori Hepatobiliary transport of a nonpeptidic endothelin antagonist, (+)-(5S,6R,7R)-2-butyl-7- [2((2S)-2-carboxypropyl)-4-methoxyphenyl]-5-(3,4-methylenedioxyphenyl) cyclopentenol[1,2-b]pyridine-6-carboxylic acid: uptake by isolated rat hepatocytes and canalicular membrane vesicles Pharm. Res. 20 2003 89 95
144. F. Tang, and R.T. Borchardt Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE Pharm. Res. 19 2002 787 793
145. J.P. Annereau, G. Szakacs, and C.J. Tucker Analysis of ABC transporter expression in drug-selected cell lines by a microarray dedicated to multidrug resistance Mol. Pharmacol. 66 2004 1397 1405
146. Y. Itoh, M. Tamai, and K. Yokogawa Involvement of multidrug resistance-associated protein 2 in in vivo cisplatin resistance of rat hepatoma AH66 cells Anticancer Res. 22 2002 1649 1653
147. Y. Cui, J. Konig, J.K. Buchholz, H. Spring, I. Leier, and D. Keppler Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells Mol. Pharmacol. 55 1999 929 937
148. P.K. Smitherman, A.J. Townsend, T.E. Kute, and C.S. Morrow Role of multidrug resistance protein 2 (MRP2, ABCC2) in alkylating agent detoxification: MRP2 potentiates glutathione S-transferase A1-1-mediated resistance to chlorambucil cytotoxicity J. Pharmacol. Exp. Ther. 308 2004 260 267
149. K. Taniguchi, M. Wada, and K. Kohno A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation Cancer Res. 56 1996 4124 4129
150. K. Koike, T. Kawabe, and T. Tanaka A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells Cancer Res. 57 1997 5475 5479
151. B. Liedert, V. Materna, D. Schadendorf, J. Thomale, and H. Lage Overexpression of cMOAT (MRP2/ABCC2) is associated with decreased formation of platinum-DNA adducts and decreased G2-arrest in melanoma cells resistant to cisplatin J. Invest. Dermatol. 121 2003 172 176
152. E. Hinoshita, T. Uchiumi, and K. Taguchi Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas Clin. Cancer Res. 6 2000 2401 2407
153. A.T. Nies, J. Konig, M. Pfannschmidt, E. Klar, W.J. Hofmann, and D. Keppler Expression of the multidrug resistance proteins MRP2 and MRP3 in human hepatocellular carcinoma Int. J. Cancer 94 2001 492 499
154. D.M. van der Kolk, E.G. de Vries, J.A. Koning, E. van den Berg, M. Muller, and E. Vellenga Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and
155. D. Steinbach, J. Lengemann, A. Voigt, J. Hermann, F. Zintl, and A. Sauerbrey Response to chemotherapy and expression of the genes encoding the multidrug resistance-associated proteins MRP2, MRP3, MRP4, MRP5, and SMRP in childhood acute myeloid leukemia Clin. Cancer Res. 9 2003 1083 1086
156. B. Laupeze, L. Amiot, and B. Drenou High multidrug resistance protein activity in acute myeloid leukaemias is associated with poor response to chemotherapy and reduced patient survival Br. J. Haematol. 116 2002 834 838
157. L.C. Young, B.G. Campling, T. Voskoglou-Nomikos, S.P. Cole, R.G. Deeley, and J.H. Gerlach Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response Clin. Cancer Res. 5 1999 673 680
158. L.C. Young, B.G. Campling, S.P. Cole, R.G. Deeley, and J.H. Gerlach Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels Clin. Cancer Res. 7 2001 1798 1804
159. Y. Soini, K. Jarvinen, R. Kaarteenaho-Wiik, and V. Kinnula The expression of P-glycoprotein and multidrug resistance proteins 1 and 2 (MRP1 and MRP2) in human malignant mesothelioma Ann. Oncol. 12 2001 1239 1245
160. I.F. Faneyte, P.M. Kristel, and M.J. van de Vijver Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer Anticancer Res. 24 2004 2931 2939
161. T.P. Schaub, J. Kartenbeck, and J. Konig Expression of the MRP2 gene-encoded conjugate export pump in human kidney proximal tubules and in renal cell carcinoma J. Am. Soc. Nephrol. 10 1999 1159 1169
162. Y. Tada, M. Wada, and T. Migita Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin Int. J. Cancer 98 2002 630 635
163. H.J. Arts, D. Katsaros, and E.G. de Vries Drug resistance-associated markers P-glycoprotein, multidrug resistance-associated protein 1, multidrug resistance-associated protein 2, and lung resistance protein as prognostic factors in ovarian carcinoma Clin. Cancer Res. 5 1999 2798 2805
164. V. Materna, J. Pleger, U. Hoffmann, and H. Lage RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response Gynecol. Oncol. 94 2004 152 160
165. M. Hirouchi, H. Suzuki, M. Itoda, S. Ozawa, J. Sawada, and I. Ieiri Characterization of the cellular localization, expression level, and function of SNP variants of MRP2/ABCC2 Pharm. Res. 21 2004 742 748